Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
Clinical trial NCT00951041 · COMPLETED
Trial details
- NCT number
- NCT00951041
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-11
- Primary completion
- 2010-08-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.